Maecenas pulvinar magna sit amet felis fringilla, nec auctor lectus facilisis. Morbi non velit lectus. Proin velit ex, lacinia at hendrerit ut, cursus sit amet eros. Nulla nec tellus imperdiet, ultrices quam eget, vulputate enim. Cras sed mi at felis porta lobortis et in lacus. Maecenas ac volutpat eros. Maecenas efficitur tellus semper congue ullamcorper. Etiam vulputate metus in efficitur porta. Phasellus non velit ut diam blandit suscipit. Suspendisse tristique facilisis tortor, ut ultrices arcu bibendum at. Quisque accumsan dui dictum, semper massa non, porttitor odio. Nulla sit amet enim neque. Donec magna risus, suscipit ut porttitor quis, hendrerit in purus. Vestibulum velit lorem, bibendum quis semper eu, facilisis vitae mi. Nam eget pellentesque lectus, et hendrerit metus. Maecenas non tristique tortor.
Timely insights and analysis from KFF staff
-
While Republicans in Congress have largely opposed the IRA and Medicare drug price negotiation, President Trump appears to be embracing it. With this latest announcement, the Trump administration can take credit for delivering lower drug prices in Medicare, while Democrats can take credit for creating the Medicare drug price negotiation program in the first place. more
-
The Administration’s change to reimbursement for drug administration services represents a step forward in implementing site neutral payment reforms but is modest compared to some of the more sweeping options raised by MedPAC and others. more
-
This policy change will likely exacerbate fears among immigrant families about health officials and providers sharing patient information with ICE, increasing their reluctance to access health coverage or care. more
Juliette Cubanski 
Zachary Levinson 
Drishti Pillai